Quantitation method for colistimethate sodium in pharmaceutical aerosol samples using high performance liquid chromatography (HPLC)

Adam Metcalf (Chichester, United Kingdom), Adam Metcalf, Lucy Hardaker, Ross Hatley

Source: International Congress 2016 – Airway biomarkers
Session: Airway biomarkers
Session type: Thematic Poster
Number: 1071
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Adam Metcalf (Chichester, United Kingdom), Adam Metcalf, Lucy Hardaker, Ross Hatley. Quantitation method for colistimethate sodium in pharmaceutical aerosol samples using high performance liquid chromatography (HPLC). Eur Respir J 2016; 48: Suppl. 60, 1071

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Delivered dose of colistimethate sodium via 3 nebulizers; a comparison of bioassay and HPLC assay results
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


The contribution of quantitative determinations through HPLC (high performance liquid chromatography), of the antituberculosis drugs in serum, in prevention of relapses
Source: Eur Respir J 2004; 24: Suppl. 48, 645s
Year: 2004

Linezolid penetrates in human pleural cavity: A pilot study using ultra-high pressure liquid chromatography in tandem with mass spectrometry (UPLC-MS/MS)
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014

Comparison of DNA strip assay and high performance liquid chromatography (HPLC) analysis of mycolic acids for identification of mycobacterial isolates to the species level
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Simultaneous measurement of inhaled air and exhaled breath by double multicapillary column ion-mobility spectrometry, a new method for breath analysis: results of a feasibility study
Source: ERJ Open Res, 8 (1) 00493-2021; 10.1183/23120541.00493-2021
Year: 2022



Quantitative determination of terbinafine (anti-aspergillar drug ) in human plasma and lung tissue by gas-chromatography and mass spectometry (GC-MS)
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002

A liquid chromatography MS/MS metabolomics study of COPD patients
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015


Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis
Source: Eur Respir J 2006; 27: 929-936
Year: 2006



A case of liquid paraffin pneumonia (pulmonary paraffinoma) defined by gaschromatography-mass spectrometry
Source: Eur Respir J 2001; 18: Suppl. 33, 221s
Year: 2001

Pharmaceutical development of a liquid formulation for pulmonary application of a peptide
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Desmosine as a biomarker of elastin degradation in COPD: current status and future directions
Source: Eur Respir J 2008; 32: 1146-1157
Year: 2008



The impact of gas analysis technique on the measurement of single breath gas transfer (TLCO)
Source: International Congress 2015 – Lung function: effects on method, machine and disease on the measurement
Year: 2015


Airway surface liquid concentrations of aztreonam lysine for inhalation in children with cystic fibrosis: A modeling study
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013

Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010


Ion mobility spectrometry – a new method in the diagnostic approach to sarcoidosis? Preliminary data
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


Investigation of the feasibility of manufacturing a spray-dried formulation of the synthetic peptide, AP301
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014


Detection of pseudomonas aeruginosa (Pa) specific peaks by ion mobility spectrometry (IMS) in exhaled breath of bronchiectasis patients
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011


Monitoring of ionic content of exhaled breath condensate in various respiratory diseases by capillary electrophoresis with contactless conductivity detection
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


A step towards easier diagnosis of lung cancer: Detection of volatile organic compounds in air releasing tumour samples with ion- and differential mobility spectrometry
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011

Clinical application of the inert gas multiple breath washout technique (MBW) in children with cystic fibrosis (CF) using a prototype ultrasonic sidestream flow sensor (US)
Source: Eur Respir J 2006; 28: Suppl. 50, 704s
Year: 2006